Nephrology patients may experience various skin issues that cause discomfort. This workshop begins with a review of the skin-kidney connection with tips for conducting a systematic skin assessment for individuals with chronic kidney disease. The potential impact of immunosuppression and medications on skin integrity, considerations for patients with tattoos, management of skin conditions such as pruritus and calciphylaxis, and wound care are covered in this comprehensive workshop.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Kristin Larson, MSN, RN, AGNP-BC, CNN – Receives salary from United Health Care; Speakers Bureau for Astra Zeneca; ANNA National Secretary.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe how to conduct a systematic skin assessment focusing on dermatological changes that occur with CKD.
This workshop focuses on safety issues and concerns encountered by nephrology nurse leaders, whether serving in formal or informal leadership roles. Topics include developing and maintaining a culture of safety; protecting patients and staff, including emergency preparedness; workplace violence and strategies to de-escalate potentially violent encounters; what to do when safety protocols fail; and how leaders can assist with recovery if a critical event occurs.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Faith Lynch, DNP, RN, CNN – Speakers Bureau and consultant for Outset Medical, Inc.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to describe leader behaviors that facilitate building a culture of safety in the workplace.
This session discusses the cultural trends and statistics on tattooing in the United States, along with the physiologic technique of tattooing. Position statements by nephrology organizations regarding the use of tattooing in chronic kidney disease and transplantation is outlined. A full skin exam on persons with tattoos and proper documentation is demonstrated and a list of hazards of tattooing, such as infection, Hepatitis C, Keloid formation, etc. is discussed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Kristin Larson, MSN, RN, AGNP-BC, CNN – Receives salary from United Health Care; Speakers Bureau for Astra Zeneca; ANNA National Secretary.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss the hazards of tattooing with their CKD patients.
This session explores patient and worker safety, including physical environment, protecting patients and staff, and emergency preparedness.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Robert Loeper, MBA, PMP – Receives salary as an employee of Fresenius.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will state an increased knowledge about improving patient and employee safety in the work environment.
This session explores pruritus, rashes, calciphylaxis, and many other chronic skin issues that make our patients’ lives uncomfortable. We discuss how to ask questions to see what impact these issues are having, along with interventions, both pharmacological and non-pharmacological.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will describe assessments and interventions to utilize in their practice related to patients experiencing pruritus.
This session explores workplace violence and types of violence (criminal, customer/client, worker on worker, personal relationship). We discuss types of threats (stalking, bullying, abusive or aggressive behavior, harassment, intimidation) and how to de-escalate in the healthcare setting.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will discuss de-escalation strategies to manage aggression in the healthcare setting.
This session explores wounds that never heal, which are a familiar problem for patients with CKD and their nephrology nurses. PVD, with all the edema and circulation issues, is discussed as to causation and pathophysiology. Assessment, treatment, and outcomes are the highlight of this session.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will employ elements of the nursing process to provide wound care for patients with CKD.
This session explores potential hazards in the workplace, along with how to plan ahead and stay alert. We discuss the impact on the workplace after a safety event and how to recover after a critical event.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will discuss how a safety event can impact the workplace despite the use of safety protocols.
It is important to care for ourselves, but if often feels like the last thing we should be doing. This important topic will make you laugh, perhaps make you cry, but most of all will make us think about how we can do self-care for ourselves, in order to give care to others.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will acknowledge the importance of self-care activities that will assist in giving care to others.
Nephrology nurses care for patients across the lifespan and likely will encounter patients who experience mental health issues. This session focuses on common mental health issues, stressors that impact mental health, and treatment options, including pharmacologic and non-pharmacologic therapies.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will describe how to assess and plan care for CKD patients experiencing mental health issues.
Advanced practice nurses often are involved in integrating advanced practice providers (APPs) into their practice. This session reviews the fundamentals needed to efficiently onboard new APPs to nephrology practice settings and explores ways to functionally manage APPs in nephrology practice settings.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to devise a plan for onboarding Advanced Practice Nurses into their practice.
This informative session is important for leaders and staff nurses alike as we explore how all nurses can be change agents. Beginning with a self-assessment of your own feelings and reactions to change, you are guided in a discussion of how to deal with change in the workplace, including maintaining staff engagement despite constant change, overcoming resistance to change, and improving staff retention.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will state how the knowledge of one’s own reactions to change can assist in decreasing resistance to change.
This session provides an update on immunization and vaccine recommendations for nephrology patients. Vaccine safety information, recommendations for immunocompromised pediatric and adult patients, and myths about COVID-19 vaccines are addressed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP – Speakers Bureau for Pfizer, Sanofi, Merck (vaccines); Idorsia (insomnia); Biohaven and AbbVie (migraines); Consultant for Pfizer, Sanofi, Merck, Moderna, Seqirus (vaccines); GSK (pain); Bayer (CKD), Idorsia (insomnia), and Shield Therapeutics (IDA).
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to articulate current and up-to-date information regarding vaccine recommendations with patients and colleagues.
Monitoring fluid and phosphorus intake and reducing interdialytic weight gain are concerns when caring for patients on dialysis. This presentation shares innovative ideas for enhancing education, incentivizing adherence, and improving clinical outcomes for pediatric patients receiving dialysis.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to utilize innovative strategies to incentivize pediatric patients to work to maintain their fluid and electrolyte levels in acceptable ranges.
Transitioning from the role of peer to manager in the workplace can be difficult, especially as your relationships with staff members change. The pros and cons of assuming a management role in your current work setting, strategies for managing relationship changes and role transitions among staff, and tips for successful orientation and goal setting are shared.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Cynthia A. Smith, DNP, APRN, CNN-NP, FNP-BC, FNKF – Contributing author for Elsevier.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will describe ways to ensure success as a new manager in your current work environment.
This session answers questions about xenotransplantation and reviews current research on cross-species transplantations. Where the future may take us as we search for ways to support individuals in need of organ transplants is also explored.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Douglas Anderson, MD - Sub-investigator on a research grant from United Therapeutics for xenotransplantation studies.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss recent developments in the research and development of xenotransplant.
This session offers valuable insight for nephrology nurses practicing in acute dialysis settings and provides an opportunity for participants to share input with experts working on a survey readiness handbook. Discussion of proposed standards for acute care settings.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Glenda Payne, MS, RN, CNN – Owner of a company developing standards for acute dialysis.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to provide input to assist with the development of standards for surveys of Acute Dialysis settings.
This session focuses on regional and national efforts to improve and increase the use of home dialysis modalities. Barriers and challenges to successful home dialysis, strategies to decrease attrition rates among individuals choosing home dialysis, and ways to grow home therapy programs in an organized and sustainable fashion is discussed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to articulate both challenges and opportunities to enable home dialysis to be a sustainable option for patients.
The broad focus of this session is on symptom-based complications of patients on dialysis. The following topics will be discussed: an introduction to KDIGO, patient perspectives on symptoms, appropriate symptom assessment in dialysis patients, and the role of nurses in symptoms management.
This session is ANCC and AANP accredited for up to 1.5 CE credits. For full CE information, go to https://kdigo.org/conferences/anna-session-on-recognizing-and-addressing-symptom-burden-in-dialysis-patients/
As a specialty practice, nephrology nursing has its own unique scope and standards of practice. This session reviews the evolution of these standards, focusing on the latest updates in the most recent edition of ANNA’s Nephrology Nursing Scope and Standards of Practice (2022).
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss the changes that have been incorporated into the 9th edition of Nephrology Nursing Scope and Standards of Practice.
Learn more about the relationship between chronic kidney disease (CKD) and diabetes, and the impact of these comorbidities on patients. This presentation will review the definition, clinical characteristics, and epidemiology of CKD. It will explore the implications of diabetes as a coexisting morbidity and discuss challenges that patients and healthcare providers face in managing these concurrent conditions. Additionally, it will highlight the importance of a collaborative approach to care for patients with CKD and diabetes.
Leaders and health policy experts from several national nursing and health professional organizations discuss the current legislative, regulatory, and policy initiatives aimed at addressing the issues affecting nurse well-being. This two-part program explores many of the issues currently straining the well-being of the nephrology nursing profession, including staffing, burnout, work environment, and COVID-19. In addition, presenters focus on what nephrology nurses can do to advocate for policies to improve their well-being in the workplace.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to verbalize the importance of advocacy for nephrology patients.
Advanced practice nurses must stay up to date on changing coding standards to maximize reimbursement for care provided. This session reviews new and updated billing guidelines for advanced practice providers and presents strategies for efficient coding/billing in various practice settings, including acute care, outpatient/office, dialysis rounds, and more.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, Advanced Practice Nurses will verbalize understanding of how to utilize the new billing guidelines for nephrology patients most appropriately and effectively.
Leaders and health policy experts from several national nursing and health professional organizations discuss the current legislative, regulatory, and policy initiatives aimed at addressing the issues affecting nurse well-being. This two-part program will explore many of the issues currently straining the well-being of the nephrology nursing profession, including staffing, burnout, work environment, and COVID-19. In addition, presenters focus on what nephrology nurses can do to advocate for policies to improve their well-being in the workplace.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Paula Dutka, MSN, RN, CNN – Clinical research for Novo Nordisk, Reata, and Outset Medical in role at NYU.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to verbalize the importance of advocacy for nephrology patients.
What is pre-emptive transplantation? Why is early referral necessary? What are the federal requirements for being listed or considered for pre-emptive transplant? Why do transplant centers have requirements for eGFR? What are the barriers to referring patients to transplant before dialysis? What are the outcomes/reasons for transplanting before dialysis? This session answers all these questions and more!
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss requirements and rational for early referral for pre-emptive transplant.
This session reviews the physiologic, psychologic, and lifestyle factors that contribute to obesity as well as the health consequences of obesity with a focus on the kidney, such as focal segmental glomerulosclerosis and inability to qualify for transplant. Treatment options, including medications, and special considerations for the pediatric population are discussed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Talat Alp Ikizler, MD – Consultant for Fresenius Kabi and Nestle.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss the implications and best practices related to pediatric obesity combined with kidney disease.
Health policy experts review key legislative, regulatory, and health policy issues affecting nephrology nursing, including value-based models. Policies that have the potential to influence nursing practice, education, and the delivery of care to patients with kidney disease are discussed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss health policy changes, particularly value-based models, and their impact to nephrology patient care and practice.
This session focuses on patients with kidney disease who also have various blood dyscrasias. Causes and symptoms of blood dyscrasias as well as medical and nursing interventions for treatment plans are highlighted. Pharmacologic therapies also are reviewed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Indumathy Varadarajan, MBBS - Consultant and Advisory Board Member for Kite Pharmaceuticals.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to verbalize elements of care planning for CKD patients with blood dyscrasias.
What is patient frailty, and how does it impact care? This session begins with a review of the criteria to determine frailty and how to evaluate patients for frailty. The significance of the results of the evaluation, recommendations for care, and strategies to improve outcomes for frail patients are discussed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss criteria for determining frailty and its anticipated impact to improving patient outcomes.
Low health literacy can be a major barrier to successful health outcomes, especially in individuals with kidney disease. Digital technologies offer an opportunity to address this barrier. This session explores options for incorporating technology to improve patient care and education, including case studies using computer-based learning, virtual reality learning, and augmented reality learning.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
Todd Maddox, PhD – Receives salary for working 10% at IKONA Health, a healthcare education company.
There are no other speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will be able to discuss the relationship of health literacy to patient outcomes.
KDIGO continues to refine guidelines for managing hypertension. This presentation highlights the updates in the most recent edition of the Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021) and discusses how these new recommendations may impact patient assessment and care.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/25/24.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures:
Christine Corbett, DNP, FNP-BC, CNN-NP, FNKF – Advisory Board Member for the National Kidney Foundation (NKF) and Speakers Bureau for GSK Anemia.
There are no other Planning Committee disclosures to declare.
Speaker Disclosures:
There are no speaker disclosures to declare.
Commercial Support:
No commercial support declared.
Accreditation Statement:
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome:
Upon completion of this activity, the learner will describe the changes in KDIGO hypertension care guidelines.